4th How to Diagnose and Treat: Multiple Myeloma

4^th How to Diagnose and Treat:
Multiple Myeloma

April 14-16, 2023 – Berlin, Germany

#ESHMM2023

Chairs: Hermann Einsele, Irene Ghobrial, Maria-Victoria Mateos

ABOUT THE CONFERENCE:
ESH How to Diagnose and Treat meetings are disease-specific meetings that address state-of-the-art diagnostic and clinical management.
They are based on the presentation and analysis of real clinical cases. Voting technology is used as a self-evaluation tool and to increase scientific interaction.

SCIENTIFIC TOPICS:
– How I treat smoldering myeloma
– How I treat newly diagnosed multiple myeloma
– From risk stratification to risk-based therapy?
– Should we use MRD testing to determine therapy in multiple myeloma?
– Is there a future role of autologous stem cell transplantation?
– How I treat relapsed multiple myeloma
– The FDA/EMEA and Foundations perspective on multiple myeloma
– Should every patient receive daratumumab in first line?
– You can’t be immune for immune therapy anymore
– Other plasma cell dyscrasias
– The future of multiple myeloma

LEARNING OBJECTIVES:
Upon completion of this CME activity, participants include:
– Update on the diagnosis and profiling of myeloma
– Upfront treatment of transplant eligible and non-eligible myeloma patients
– Treatment of relapsed myeloma patients
– Risk-adapted therapy
– Immune therapy
– Diagnosis and treatment of plasma cell dyscrasias other than multiple myeloma

THE PROGRAMME WILL INCLUDE:
– Plenary Sessions
– Interactive Case Presentations
– Roundtables
– Panel Discussions
– Debates
– Poster Walks
– Meet the Expert Sessions
– Voting technology

CME Accredidation:

The programme of the 4th How to Diagnose and Treat: Multiple Myeloma has been reviewed and approved for CME accreditation by the European Board for Accreditation in Haematology (EBAH). The EHA-CME Unit has approved this educational activity for a maximum number of 17 CME credits. Each physician should only claim credits for time that she/he actually spent in the educational activity.

The 4th How to Diagnose and Treat: Multiple Myeloma is committed to providing unbiased, balanced and objective educational and scientific programmes. In accordance with EBAH guidelines, all planners and speakers are asked to provide disclosures of their relevant financial relationships, which are available for audience review via a slide presentation. The CME provider has a mechanism in place to identify and resolve any conflicts of interest prior to the start of each presentation. Audience members will be asked to assess each presentation for the presence/absence of commercial bias.

CLICK HERE to access the final scientific programme.

EHA-CME ACCREDITATION:

This Conference programme has been reviewed and approved by EBAH for 17 CME-CPD credits.

Abstract submission is CLOSED!

Clinical Cases and abstracts are eligible to be selected for an oral or a poster presentation.

Clinical Case Presentation:

• Clinical cases must be relevant to the topic of the meeting. 
• Maximum number of words: 500 
• Your clinical case will be submitted to peer review. 

 Abstracts:

• Your abstract can be structured (eg Objectives, Methods, Results, Conclusions) or unstructured. 
• Maximum number of words: 500 
• Your abstract will be submitted to peer review.

Friday, April 14, 2023

14:05-15:05 SATELLITE SYMPOSIUM
From clinical trials to real world practice: the role of anti-BCMA treatments in Relapse/Refractory multiple myeloma
Chair: Stefan Knop (Nuremberg)
Speakers: Elena Zamagni (Bologna), Leo Rasche (Würzburg), Stefan Knop (Nuremburg)

This event is organised and sponsored by GSK and is intended for healthcare professionals with an interest
in multiple myeloma

Saturday, April 15, 2023

08:50-09:50 SATELLITE SYMPOSIUM
On the case: Practical discussions and clinical decisions in managing hard-to-treat multiple myeloma populations
Chair: Stefan Knop (Erlangen)
Speakers: Ceri Bygrave (Cardiff), Stefan Knop (Erlangen), Albert Oriol (Barcelona)

This symposium is organised and sponsored by Sanofi

13:15-14:15 SATELLITE SYMPOSIUM
Treatment choices in early RRMM: an expert discussion
Chair: Marc Raab (Heidelberg)
Speakers: Francesca Gay (Turin), Martin Kortüm (Würzburg), Marc Raab (Heidelberg)

Satellite Symposium sponsored by Celgene, a Bristol Myers Squibb company

Sunday, April 16, 2023

08:55-09:55 SATELLITE SYMPOSIUM
Exploring a Fractured Timeline of Different Decisions: How Can We Optimise Outcomes in Multiple Myeloma?
Chair: Philippe Moreau (Nantes)
Speakers: Philippe Moreau (Nantes), Paula Rodriguez-Otero (Pamplona), Katja Weisel (Hamburg)

This symposium is organized by PeerVoice and supported by an educational grant from GSK plc.

Vienna House Andels’ Berlin Hotel (the conference venue)

In order to help you with your travel planning, a number of rooms have been blocked
at a special rate for you.

To book your accommodation at a preferential rate, please call the reservation department under 0049 30 453 053 2200

or send an email to reservation.andels-berlin@hrg-hotels.com.

Please mention ESH Multiple Myeloma 2023 on your booking

—-

Warning!
We have detected scam activity of a company trying to sell accommodation services to the speakers of our conferences. Apparently, they have been collecting information on the speakers from the lists that are made public on our websites.
Please make sure you book your accommodation either via the link(s) provided by ESH on this page, or directly with the hotel or renown booking services platform.

Vienna House Andel’s Berlin
Landsberger Allee 106, 10369 Berlin, Germany

Vienna House Andel’s Berlin is located in the district of Lichtenberg, on the border with Prenzlauer Berg and Friedrichshain.

https://www.viennahouse.com/en/andels-berlin/location.html

With the support of*:

Major Conference Partners
*******

Level 1 Conference Partner
*******

Level 2 Conference Partners
*******

Supporting Conference Partner
*******

*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.

REGISTRATION IS CLOSED.

The registration fee for the ESH 4th How to Diagnose and Treat Multiple Myeloma is:

– 600€ for fully trained

– 300€ for in-training *

– 300€ Allied Health Professionals

– 600€ for Corporate

*A proof will be requested to confirm your status.

ESH is pleased to offer BSH, DGHO and PTHiT Members a 20% discount on the conference registration fees.

This fee includes:

• Your seat in the Conference Room
• The conference materials,
• Welcome cocktail, luncheons, refreshments throughout the conference.

Your seat in the conference will be definitively reserved upon receipt of your fee.

How to proceed :

Please make sure that your Internet browser (Firefox, Internet Explorer, Safari, Google Chrome…) is up-to-date. Using an old version may prevent you from visualising the full website content.

1. A) For Individual Registration:
2. Click on REGISTER HERE at the bottom of the page
3. Click on INDIVIDUAL REGISTRATION
4. Create an account and complete the registration form. It is very important to use the email of the participant in the form.
5. Proceed with the payment.
6. B) For Group Registration (More than one person):
7. Click on REGISTER HERE at the bottom of the page
8. Click on GROUP REGISTRATION
9. Create an account and fill in the complete details for each person that you would like to register (Use the personal email address of each participant you are registering, failure to do so will prohibit you from completing the registrations.)
10. Proceed with payment.

Cancellation policy of registration fee :

In case of cancellation, up until two months prior to the beginning of the meeting, your registration fee will be reimbursed in full (less bank charges). If the cancellation is notified between 60 to 15 days prior to the beginning of the meeting, 50% of the registration fee will be reimbursed (less bank charges). Cancellations notified 15 days before the meeting will not be reimbursed. For credit card payments please register on-line first. Please note that ESH can accept VISA and MASTERCARD/EUROCARD.